Document:

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.5  

 
 

NEWPORT FAB, LLC CONTRIBUTION AGREEMENT    
    

between:

CONEXANT SYSTEMS, INC.,

a Delaware corporation 

and 

NEWPORT FAB, LLC,

a Delaware limited liability company. 

Dated as of February 23, 2002 

   

    

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
TABLE OF CONTENTS  

	 
	 	 
	 	 
	 	Page

	1.	 	CONTRIBUTION OF ASSETS; RELATED TRANSACTIONS	 	1
	

 	
 	

1.1	
 	

Contributions by Conexant	
 	

1
	

 	
 	

1.2	
 	

Consideration for Contributed Assets	
 	

3
	

 	
 	

1.3	
 	

Sales Taxes	
 	

4
	

 	
 	

1.4	
 	

Closing	
 	

4
	

2.	
 	

MISCELLANEOUS PROVISIONS	
 	

4
	

 	
 	

2.1	
 	

Further Assurances	
 	

4
	

 	
 	

2.2	
 	

Governing Law	
 	

5
	

 	
 	

2.3	
 	

Successors and Assigns; Parties in Interest	
 	

5
	

 	
 	

2.4	
 	

Remedies Cumulative; Specific Performance	
 	

5
	

 	
 	

2.5	
 	

Waiver	
 	

5
	

 	
 	

2.6	
 	

Construction	
 	

5
	

 	
 	

2.7	
 	

Dispute Resolution; Arbitration	
 	

5

i

   NEWPORT FAB, LLC CONTRIBUTION AGREEMENT  

        THIS NEWPORT FAB, LLC CONTRIBUTION AGREEMENT (this "Agreement") is
entered into as of February 23, 2002, by and between: CONEXANT SYSTEMS, INC., a Delaware corporation ("Conexant"); and NEWPORT FAB, LLC, a
Delaware limited liability company ("the Company"). Certain capitalized terms used in this Agreement are defined in  Exhibit A.

RECITALS  

        WHEREAS, Conexant currently conducts, and historically has conducted, semiconductor wafer fabrication and
manufacturing operations at Conexant's Newport Beach California facilities (the "Wafer Fabrication Operations"), which operations include (i) the
semiconductor wafer fabrication and probing operations located at the facilities surrounding, or physically housed, either in part or in whole, in Buildings 501, 503 and 505 located at 4311 Jamboree
Road, Newport Beach, California (buildings 503 and 505 being referred to collectively as the "El Capitan Buildings") and (ii) certain research
and development, design support service and other support operations ("Wafer Fabrication Support Operations"); and 

        WHEREAS, Conexant wishes to contribute to the Company and the Company wishes Conexant to contribute to the Company certain assets related
to the Wafer Fabrication Operations, in exchange for all the membership and other ownership interests in the Company (the "Membership Interests"). 

AGREEMENT  

        NOW, THEREFORE, the parties to this Agreement, intending to be legally bound, agree as follows: 

1.    CONTRIBUTION OF ASSETS; RELATED TRANSACTIONS.

        1.1    Contributions by Conexant.    

         (a)   Conexant shall contribute, assign, transfer, convey and deliver to the Company, and the Company shall accept from Conexant, at the
Closing (as
defined in Section 1.4), good and valid title to the Contributed Assets, free and clear of any Encumbrances, other than Permitted Encumbrances, on the terms and subject to the conditions set
forth in this Agreement. For purposes of this Agreement, "Contributed Assets" shall mean all right, title, and interest of Conexant in and to only the
following assets and properties: 

         (i)    except as set forth on Schedule 1.1(a)(i)(1), all equipment, machinery, computers, tools, trade fixtures, improvements
(including waste
treatment and pollution control systems, raised floors, walls, HEPA filters, exhaust ductwork, gas and liquid lines, etc.) supplies, materials, furniture, and other tangible personal property used or
held for use in the conduct of the Wafer Fabrication Operations and that are physically located within the blue shaded areas on the floor plan building schematics for Buildings 503 and 505 located at
4311 Jamboree Road, Newport Beach, California attached hereto as Schedule 1.1(a)(i)(2) (the "Identified WFO Property"), and all furniture,
personal computers, calculators and other personal property used by or held for use by the Transferred Employees (the "Transferred Employees'
Property"); 

         (ii)   all equipment, machinery, computers, tools, fixtures, supplies, materials, furniture, and other tangible property related to the Wafer
Fabrication Support Operations that are specifically listed on Schedule 1.1.(a)(ii) (together with the Identified WFO Property and the Transferred Employees' Property, the
"Tangible Personal Property"); 

         (iii)   the Inventory owned by Conexant as of the Closing Date (as defined in Section 1.4); 

1

 

        (iv)  the spare parts used in the Wafer Fabrication Operations and owned by Conexant as of the Closing Date; 

         (v)   all contracts listed on Schedule 1.1(a)(v), including any purchase orders related to such contracts (the  "Transferred Contracts"); 

         (vi)  except as set forth on Schedule 1.1(a)(vi)(1) and except for any patent and patent applications not listed on
Schedule 1.1(a)(vi)(1) that are primarily related to the Product Technology (collectively, the "Excluded Patent Rights"), the patent and patent
applications set forth on Schedule 1.1(a)(vi)(2) and all other patents, patent applications and worldwide patent rights to all invention disclosures (which invention disclosures have been
submitted to Conexant in writing as of the date of the Closing) primarily related to the Process Technology (collectively, the "Transferred Patents").
Notwithstanding the foregoing, the Excluded Patent Rights shall not include any patents, patent applications or disclosures set forth on Schedule 1.1(a)(vi)(2); 

        (vii)   the know-how, trade secrets and other intellectual property primarily related to the Process Technology, including,
without limitation, the know how, trade secrets, and other intellectual property rights described on Schedule 1.1(a)(vii) (collectively, the "Transferred
Know-How"); 

         (viii)   all Governmental Authorizations primarily relating to the operation of the Wafer Fabrication Operations, to the extent such
Governmental Authorizations are transferable by Conexant in connection with the transactions contemplated by this Agreement (the "Transferred Permits"); 

         (ix)  all claims, causes of action and rights of set-off relating to any of the Contributed Assets, other than claims, causes of action
and rights of set-off for infringement, misappropriation or violation of the Transferred Intellectual Property that occurred prior to the Closing Date; and 

         (x)   (a) all records and lists of Conexant primarily relating to the Wafer Fabrication Operations and the assets described in clauses
(i) through (ix) of this Section 1.1, including without limitation all records and lists pertaining to all external customers and suppliers of and to the Wafer Fabrication
Operations, (b) all product, business, and marketing plans of Conexant primarily pertaining to the Wafer Fabrication Operations, (c) all books, ledgers, files, reports, plans, drawings,
and operating records related primarily to the Wafer Fabrication Operations or the assets described in clauses (i) through (ix) of this Section 1.1, and (d) to the extent
permitted by applicable Legal Requirements, personnel records for all Transferred Employees (collectively, the "Books and Records"); provided that
Conexant shall be entitled to retain a copy of such Books and Records for internal use. 

        (b)   Notwithstanding anything in this Agreement to the contrary, (i) all assets of Conexant not specifically identified as a Contributed
Asset
under Section 1.1(a) (including but not limited to those assets set forth in Schedule 1.1(a)(i)(1) and all assets physically located in the unshaded areas on the floor plan building
schematics for Buildings 503 and 505 located at 4311 Jamboree Road, Newport Beach,
California, attached hereto as Schedule 1.1(a)(i)(2)) above and (ii) the assets listed on Schedule 1.1(b) and the assets physically located in the unshaded area on the floor plan
attached to Schedule 1.1(b) (the assets listed on Schedule 1.1(b) being referred to as the "Specified Excluded Assets") shall not be
contributed or transferred hereunder, shall be excluded from the definition of Contributed Assets and shall remain the property of Conexant. 

         (c)   Following the Closing, and for a period of eighteen (18) months thereafter, the parties shall cooperate with each other to identify
any
assets that were (i) not designated as part of the Contributed Assets at the Closing but which relate primarily to the Wafer Fabrication Operations 

2

 

(the  "Nontransferred WFO Assets"), and (ii) designated as part of the Contributed Assets but which do not relate to the Wafer Fabrication
Operations and which should not have been transferred to the Company (the "Transferred Conexant Assets"). To the extent that any Transferred Conexant
Assets are identified and the Company is legally and contractually permitted to transfer such assets, then the Company shall, [...***...] take all actions to transfer the
Transferred Conexant Assets to Conexant. In the event that the Company is required to obtain the consent or approval of any Person prior to the transfer of any Transferred Conexant Assets, then the
Company shall, [...***...] obtain such approval or consent, and upon obtaining such approval or consent, shall promptly transfer such Transferred Conexant Assets to Conexant.
To the extent any Nontransferred WFO Assets are identified and Conexant is legally and contractually permitted to transfer such assets, Conexant shall, [...***...] take all
actions to transfer such Nontransferred WFO Assets to the Company. In the event Conexant is required to obtain the consent or approval of any Person prior to the transfer of any Nontransferred WFO
Asset, then Conexant shall, [...***...] obtain such approval or consent, and upon obtaining such approval or consent, shall promptly transfer such Nontransferred WFO Asset to
the Company. In the event Conexant is unable to obtain such approval or consent, then Conexant and the Company shall discuss in good faith an appropriate resolution for the disposition of such
Nontransferred WFO Asset. In the event Conexant and the Company are unable within a reasonable period of time to agree upon an appropriate resolution with respect to the transfer of any Transferred
Conexant Asset or Nontransferred WFO Asset as the case may be, then such dispute shall be resolved in accordance with the arbitration procedures set forth in Section 2.7. Notwithstanding the
foregoing, Conexant shall not be obligated to transfer to the Company any Nontransferred WFO Asset unless the Company shall make arrangements to provide Conexant with the benefit of such asset to the
extent such asset is used in Conexant's other operations. Notwithstanding any provision of this Agreement to the contrary, nothing herein shall be deemed to constitute an agreement to assign any
Transferred Contract or any right or privilege arising thereunder if an attempted assignment thereof, without the consent of the other party or parties thereto, would constitute a breach thereof
unless such consent has been obtained. 

        1.2    Consideration for Contributed Assets.    

         (a)   As consideration for the contribution of the Contributed Assets by Conexant to the Company set forth in Section 1.1 above, the
Company
shall: 

         (i)    at the Closing, issue to Conexant 100% of the Membership Interests in the Company; and 

        (ii)   at the Closing, assume the Assumed Liabilities (as defined in Section 1.2(b)) and be responsible for their timely discharge or
satisfaction. 

         (b)   For purposes of this Agreement "Assumed Liabilities" shall mean only the following
liabilities: 

         (i)    all Liabilities arising under or out of the Transferred Contracts (other than Liabilities arising out of breaches or violations by
Conexant
occurring prior to the Closing Date) for performance of or payments to be made under the Transferred Contracts that accrue in respect of events following the Closing Date;  provided however, that any
payment obligations arising under the Transferred Contracts for products or services received by Conexant prior to the
Closing Date shall not be deemed an Assumed Liability, and Conexant shall remain liable for any such payments; 

         (ii)   all employment related liabilities set forth on Schedule 1.2(b)(ii); 

         (iii)   all Liabilities arising, accruing or occurring under or out of that certain Labor Agreement, effective May 1, 1998 between
Conexant and Local Union No. 2295 of the International Brotherhood of Electrical Workers (the "Collective Bargaining Agreement") on or after
May 1, 2002 to the extent provided in the Employee Matters Agreement; 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

3

 

         (iv)  all Liabilities other than Excluded Liabilities arising on or after the Closing Date out of the ownership or use of the Contributed Assets or
the conduct of the Wafer Fabrication Operations by the Company on or after the Closing Date; 

        (v)   all Liabilities related to the capital expenditures and other acquisition commitments identified on Schedule 1.2(b)(v); 

         (c)   Except as specifically set forth in Section 1.2(b), the Company shall not assume any Liabilities of Conexant, whether arising out of
the
Wafer Fabrication Operations or otherwise (the "Excluded Liabilities"), including without limitation any liabilities related to or arising from
employment, employee benefits and employee benefit plans, the ownership of the Contributed Assets, Taxes, compliance with Legal Requirements, or any breaches or violations under the Transferred
Contracts, in each case, accruing, arising out of, or relating to events and occurrences prior to the Closing. 

        1.3    Sales Taxes.    Conexant shall be responsible for, and shall pay and reimburse the Company, and/or its
Affiliates, as applicable, for, any sales taxes, use taxes, transfer taxes, documentary charges, recording fees, stamp taxes or similar taxes, charges, fees or expenses (collectively  "Sales and Transfer
Taxes") that may become payable in connection with the contribution of the Contributed Assets, assumption of the Assumed
Liabilities, and issuance of the Membership Interests as contemplated hereby. The Company and Conexant shall cooperate with each other in timely making all filings, returns, report and forms as may be
required in connection with the payment of all Sales and Transfer Taxes, including but not limited to delivering all instruments and certificates as are necessary to minimize such Sales and Transfer
Taxes and enable the other to timely comply with the filing of any Tax Return that relates to Sales and Transfer Taxes.

        1.4    Closing.    

        (a)   The closing of the transactions contemplated by Sections 1.1, 1.2 and 1.3 and the other transactions contemplated hereby (the
"Closing") shall take place at the offices of Cooley Godward LLP, located at 4401 Eastgate Mall, San Diego, California, at 9:00 a.m. (Pacific
Standard Time) concurrently with the execution of this Agreement. For purposes of this Agreement, "Closing Date" shall mean the date as of which the
Closing actually takes place. 

         (b)   At the Closing: 

        (i)    Conexant shall execute and deliver to the Company such bills of sale, endorsements, assignments and other documents as may be
necessary or
appropriate to assign, convey, transfer and deliver to the Company the Contributed Assets; 

         (ii)   Conexant and the Company shall execute and deliver to each other the Assignment and Assumption Agreement in a form reasonably acceptable
to
Conexant and the Company (the "Assignment and Assumption Agreement"); and 

        (iii)   the Company shall issue to Conexant certificates evidencing the Membership Interests contemplated by Section 1.2(a)(i). 

2.    MISCELLANEOUS PROVISIONS.  

        2.1    Further Assurances.    Each party hereto shall execute and/or cause to be delivered to each other party hereto
such instruments and other documents, and shall take such other actions, as such other party may reasonably request (prior to, at or after the Closing) for the purpose of carrying out or evidencing
any of the transactions. 

4

 

        2.2    Governing Law.    This Agreement shall be construed in accordance with, and governed in all respects by, the
internal laws of the State of Delaware (without giving effect to principles of conflicts of laws). 

        2.3    Successors and Assigns; Parties in Interest.    This Agreement shall be binding upon and inure to the benefit
of the Company and Conexant, and the respective successors and assigns (if any) of the foregoing. 

        2.4    Remedies Cumulative; Specific Performance.    The rights and remedies of the parties hereto shall be cumulative
(and not alternative). The parties hereto agree that: (a) in the event of any breach or threatened breach by any party of any covenant, obligation, or other provision of this Agreement
applicable to such party, the other party shall be entitled (in addition to any other remedy that may be available) to (i) a decree or order of specific performance or mandamus to enforce the
observance and performance of such covenant, obligation or other provision, and (ii) an injunction restraining such breach or threatened breach; and (b) such other party shall not be
required to provide any bond or other security in connection with any such decree, order or injunction or in connection with any related action or Proceeding. 

        2.5    Waiver.    

        (a)   No failure on the part of any Person to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of
any
Person in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such
power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. 

         (b)   No Person shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this
Agreement,
unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Person; and any such waiver shall not be
applicable or have any effect except in the specific instance in which it is given. 

        2.6    Construction.    

         (a)   For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the
masculine gender
shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include the masculine and feminine genders. 

         (b)   The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall
not be
applied in the construction or interpretation of this Agreement. 

         (c)   All monetary amounts referenced herein are denominated in United States Dollars. 

        (d)   As used in this Agreement, the words "include" and "including," and variations thereof, shall not be deemed to be terms of limitation, but
rather
shall be deemed to be followed by the words "without limitation." 

         (e)   Except as otherwise indicated, all references in this Agreement to "Sections" and
"Exhibits" are intended to refer to Sections of this Agreement and Exhibits to this Agreement. 

        2.7    Dispute Resolution; Arbitration.    

         (a)   The parties hereto will act in good faith and use commercially reasonable efforts to promptly resolve any claim, dispute, controversy or
disagreement arising out of or relating to or in connection with this Agreement or the breach, termination or validity hereof (each a "Dispute") 

5

 

between
the parties or any of their respective subsidiaries or affiliates under or related to this Agreement or any of the transactions contemplated hereby. 

         (b)   Upon the written request (a "Request") of any party, the relevant parties shall
commence good
faith negotiations with the goal of resolving the Dispute on a mutually satisfactory basis. If the Dispute has not been resolved to the satisfaction of all relevant parties within fifteen
(15) calendar days after the date on which the Request is delivered, the Dispute shall immediately be referred to senior officers of each relevant party. The senior officers of each party
(e.g., chief executive officer and/or chief financial officer or senior or executive vice president) shall meet immediately, and in no case later than
30 calendar days after the date on which the Request is delivered, for a minimum of two business days with a mutually selected mediator and attempt in good faith to negotiate a resolution of the
Dispute. If the parties are unable to resolve the Dispute within 35 calendar days after the date on which the Request is delivered, then any relevant party may submit the Dispute to arbitration as the
exclusive means of resolving it in accordance with the procedures set forth in this Section. 

        (c)   Except as otherwise specified in this Section, any Dispute not resolved through the procedure set forth above shall be finally settled by
arbitration in accordance with the Rules and Procedures of the
American Arbitration Association (the "Arbitration Rules"), which are deemed to be incorporated by reference herein except as otherwise modified herein. 

         (d)   The arbitration situs shall be Wilmington, Delaware, and the laws of the State of Delaware shall be applied. 

        (e)   In the event of an arbitration involving two parties, there shall be one arbitrator who shall be jointly nominated by such parties. In the
event
of an arbitration involving more than two parties, there shall be three arbitrators who shall be jointly nominated by the parties. If the parties fail to so nominate the arbitrators within
30 days from the date when the Dispute is submitted to arbitration pursuant to this Section, at the request of any party, the arbitrator(s) shall be appointed in accordance with the Arbitration
Rules. 

         (f)    The arbitration hearing shall commence no later than 30 days following the appointment of the sole arbitrator or after the
appointment of
the last of the three arbitrators, as the case may be, and the final award shall be rendered no later than 30 calendar days following the close of the hearing. 

         (g)   Consistent with the expedited nature of arbitration, each party will, upon the written request of the other party, provide the other with
copies
of documents relevant to the issue raised by any claim or counterclaim. Other discovery may be ordered by the panel to the extent the panel deems additional discovery relevant and appropriate, and any
dispute regarding discovery, relevance or scope thereof, shall be determined by the panel, which determination shall be conclusive. 

        (h)   By agreeing to arbitration, the parties do not intend to deprive any court of its jurisdiction to issue a pre-arbitral injunction,
pre-arbitral attachment, injunctive or other equitable relief or an order in aid of arbitration proceedings and the enforcement of any award. Without prejudice to such provisional remedies
in aid of arbitration as may be available under the jurisdiction of a national court, the arbitral tribunal shall have full authority to grant provisional remedies and to award damages for the failure
of any party to respect the arbitral tribunal's orders to that effect. 

         (i)    The award shall be final and binding upon the parties, and shall be the sole and exclusive remedy between the parties regarding any
claims,
counterclaims, issues, or accounting presented to the arbitral tribunal in connection with the Dispute. Judgment upon any award may be entered in any court having competent jurisdiction thereof. 

6

 

         (j)    The costs of the arbitration shall be borne as determined in accordance with the Arbitration Rules; provided,

however, that to the extent a party is non-prevailing or unsuccessful on a claim in an arbitration proceeding under this Section, as determined by the
arbitrator(s), that party shall pay the prevailing or successful party's costs and expenses incurred in connection with the arbitration of that Dispute, including attorneys' fees and arbitration
expenses, whether or not such Dispute is prosecuted to award or judgment. 

         (k)   Subject to the receipt of any applicable governmental approval, any monetary award shall be made and promptly payable in U.S. dollars if
due in
U.S. dollars, free of any deduction or offset, and the arbitral tribunal shall be authorized in its discretion to grant pre-award and post-award interest at commercial rates.
The arbitral tribunal shall have the authority to award any remedy or relief proposed by the claimants or respondents pursuant to this Agreement, including without limitation, a declaratory judgment,
specific performance of any obligation created under this Agreement or the issuance of an injunction. 

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

7

 

        The
parties to this Agreement have caused this Agreement to be executed and delivered as of the date first above written. 

	 	 	CONEXANT SYSTEMS, INC.,

a Delaware corporation
	 	 	 	 
	 	 	 	 
	 	 	By:	/s/  DWIGHT DECKER      
 Name:  Dwight Decker

Title:    Chief Executive Officer
	 	 	 	 
	 	 	NEWPORT FAB, LLC

a Delaware limited liability company
	 	 	 	 
	 	 	 	 
	 	 	By:	/s/  SCOTT SILCOCK      
 Name:  Scott Silcock

Title:    Director of Operations

[SIGNATURE PAGE TO NEWPORT FAB, LLC CONTRIBUTION AGREEMENT] 

8

   EXHIBIT A

 CERTAIN DEFINITIONS  

        For purposes of the Agreement (including this Exhibit A): 

        "Affiliate" shall mean, with respect to any Entity, any other Entity controlled by, controlling, or under common control with such first
Entity. 

        "Agreement" shall mean the Asset Contribution Agreement to which this Exhibit A is
attached (including the Conexant Disclosure Schedule and the Carlyle Disclosure Schedule), as it may be amended from time to time. 

        "Contract" shall mean any written agreement, contract, instrument, note, guaranty, indemnity, representation, warranty, deed, assignment,
power of attorney, certificate, purchase order, work order, insurance policy, benefit plan or commitment of any nature. 

        "Encumbrance" shall mean any lien, pledge, hypothecation, mortgage, security interest, encumbrance, claim, lease, license, Order,
imperfection of title, condition or restriction (including any restriction on the transfer of any asset, any restriction on the receipt of any income derived from any asset, any restriction on the use
of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset). 

        "Entity" shall mean any corporation (including any non-profit corporation), general partnership, limited partnership, limited
liability partnership, joint venture, estate, trust, cooperative, foundation, society, political party, union, company (including any limited liability company or joint stock company), firm or other
enterprise, association, organization or entity. 

        "Governmental Authorization" shall mean any permit, license, certificate, franchise, approval, consent, certification, designation,
registration, qualification or authorization issued or granted by any Governmental Body. 

        "Governmental Body" shall mean any: (a) nation, principality, state, commonwealth, province, territory, county, municipality,
district or other jurisdiction; (b) federal, state, local, municipal or foreign government (including any agency, department, bureau, division, court, or other administrative or judicial body
thereof); or (c) governmental or quasi-governmental authority of any nature. 

        "Intellectual Property" shall mean any and all worldwide (a) rights associated with works of authorship, including copyrights,
moral rights, and mask works; (b) trademark and trade name rights and similar rights; (c) trade secret rights; (d) patents and patent rights; (e) other proprietary rights
in know-how, inventions, ideas, algorithms, formula, methods, processes, techniques, proprietary information, software, semiconductor devices, and other types of technology; and
(f) all registrations, applications, renewals, extensions, combinations, divisions, or reissues of the foregoing. 

        "Inventory" shall mean those items of raw materials and work-in-process used to manufacture semiconductor wafers
at the Newport Beach Fab Facility or otherwise related to the Wafer Fabrication Operations. 

        "Legal Requirement" shall mean any federal, state, foreign, local or municipal law, statute, legislation, constitution, ordinance, code,
edict, rule, regulation, ruling, directive, pronouncement, or interpretation issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the
authority of any Governmental Body. 

        "Liability" shall mean any debt, obligation, duty or liability of any nature (including any unknown, undisclosed, unmatured, unaccrued,
unasserted, contingent, indirect, conditional, implied, vicarious, derivative, joint, several or secondary liability). 

A-1

 

        "Newport Beach Fab Facility" shall mean Conexant's semiconductor wafer manufacturing facility located in buildings 501, 503 and 505 at
4311 Jamboree Road, Newport Beach, California, together with any other real property used in the Wafer Fabrication Operations. 

        "Order" shall mean any order, judgment, injunction, edict, decree, ruling, pronouncement, determination, decision, opinion, verdict,
sentence, subpoena, writ or award issued, made, entered,
rendered or otherwise put into effect by or under the authority of any Governmental Body or any arbitrator or arbitration panel. 

        "Permitted Encumbrance" shall mean (i) any Encumbrance for Taxes not yet due and payable or which are being contested in good faith
through appropriate proceedings for which adequate reserves have been established in accordance with GAAP on the financial statements, (ii) any Encumbrance with respect to leased equipment that
exists under the express terms of any equipment lease included in the Contributed Assets, and (iii) liens of landlords and liens of carriers, warehousemen, mechanics and materialmen and other
like liens arising in the ordinary course of business for sums not yet due and payable or which are being contested in good faith through appropriate proceedings for which adequate reserves have been
established in accordance with GAAP on the financial statements. 

        "Person" shall mean any individual, Entity or Governmental Body. 

        "Proceeding" shall mean any action, suit, litigation, arbitration, or investigation (including any civil, criminal or administrative)
commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Body or any arbitrator or arbitration panel. 

        "Process Technology" shall mean: [...***...] 

        "Product Technology" shall mean [...***...] 

        "Representatives" shall mean officers, directors, employees, shareholders, agents, attorneys, accountants, advisors and representatives. 

        "Tax" shall mean any tax (including any income tax, franchise tax, capital gains tax, estimated tax, gross receipts tax, value-added tax,
surtax, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, occupation tax, inventory tax, occupancy tax, withholding tax or payroll tax), levy,
assessment, tariff, impost, imposition, toll, duty (including any customs duty), deficiency or fee, and any related charge or amount (including any fine, penalty or interest), that is, has been or may
in the future be (a) imposed, assessed or collected by or under the authority of any Governmental Body, or (b) payable pursuant to any tax-sharing agreement or similar
Contract. 

        "Tax Return" shall mean any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including
any schedule or attachment thereto, and including any amendment thereof. 

        "Transferred Employees" shall mean those employees of Conexant who become employees of the Company. 

        "Transferred Intellectual Property" shall mean collectively the Transferred Patents and the Transferred Know-How. 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

A-2

 
 

DISCLOSURE SCHEDULE
  to
  NEWPORT FAB, LLC CONTRIBUTION AGREEMENT
  Dated as of February 23, 2002
  by and among
  CONEXANT SYSTEMS, INC. and NEWPORT FAB, LLC    
    

        This disclosure schedule ("Disclosure Schedule") is being furnished by Conexant Systems, Inc., a Delaware
corporation ("Conexant") to Newport Fab, LLC, a Delaware limited liability company ("Newport Fab"), in
connection with the execution and delivery of that certain Newport Fab, LLC Contribution Agreement dated as of February 23, 2002 by and between Conexant and Newport Fab (the
"Agreement"). Unless the context otherwise requires, all capitalized terms used in this Disclosure Schedule shall have the respective meanings assigned
to them in the Agreement. 

        No
reference to or disclosure of any item or other matter in this Disclosure Schedule shall be construed as an admission or indication that such item or other matter is material or that
such item or other matter is required to be referred to or disclosed in this Disclosure Schedule. No disclosure in this Disclosure Schedule relating to any possible breach or violation of any
agreement, law or regulation shall be construed as an admission or indication that any such breach or violation exists or has actually occurred. 

        This
Disclosure Schedule and the information and disclosures contained in this Disclosure Schedule are intended only to qualify and limit the representations, warranties and covenants of
Conexant contained in the Agreement and shall not be deemed to expand in any way the scope or effect of any such representation, warranties or covenants. 

        The
bold-faced headings contained in this Disclosure Schedule are included for convenience only, and are not intended to limit the effect of the disclosures contained in this Disclosure
Schedule or to expand the scope of the information required to be disclosed in this Disclosure Schedule. 

 
 

SCHEDULE 1.1(a)(i)(1)    
    
    EXCLUDED ASSETS    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(a)(i)(2)    
    
    MAP    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(a)(ii)    
    
    TANGIBLE PERSONAL PROPERTY    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(a)(v)    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(a)(vi)(1)    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(a)(vi)(2)    
    
    PATENTS, APPLICATIONS AND DISCLOSURES BEING TRANSFERRED TO COMPANY    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(a)(vii)    
    
    KNOW-HOW    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.1(b)    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.2(b)(ii)    
    
    Employment Related Liabilities to be Assumed by the Joint Venture    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 
 

SCHEDULE 1.2(b)(v)    
    
    ASSUMED LIABILITIES RELATED TO CAPITAL EXPENDITURES AND    
    
    OTHER ACQUISITION COMMITMENTS    
    

        [...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

QuickLinks

NEWPORT FAB, LLC CONTRIBUTION AGREEMENT

DISCLOSURE SCHEDULE to NEWPORT FAB, LLC CONTRIBUTION AGREEMENT Dated as of February 23, 2002 by and among CONEXANT SYSTEMS, INC. and NEWPORT FAB, LLC

SCHEDULE 1.1(a)(i)(1) EXCLUDED ASSETS

SCHEDULE 1.1(a)(i)(2) MAP

SCHEDULE 1.1(a)(ii) TANGIBLE PERSONAL PROPERTY

SCHEDULE 1.1(a)(v)

SCHEDULE 1.1(a)(vi)(1)

SCHEDULE 1.1(a)(vi)(2) PATENTS, APPLICATIONS AND DISCLOSURES BEING TRANSFERRED TO COMPANY

SCHEDULE 1.1(a)(vii) KNOW-HOW

SCHEDULE 1.1(b)

SCHEDULE 1.2(b)(ii) Employment Related Liabilities to be Assumed by the Joint Venture

SCHEDULE 1.2(b)(v) ASSUMED LIABILITIES RELATED TO CAPITAL EXPENDITURES AND OTHER ACQUISITION COMMITMENTSQuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.6    
    

 
 

IP LICENSE AGREEMENT    
    

between:

SPECIALTYSEMI, INC.,

a Delaware corporation; 

and 

CONEXANT SYSTEMS, INC.,

a Delaware corporation 

Dated as of March 12, 2002 

   

    

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

IP LICENSE AGREEMENT  

        THIS IP LICENSE AGREEMENT (this "Agreement") is entered into as of
March 12, 2002 (the "Effective Date") by and between Conexant Systems, Inc., a Delaware
corporation ("Conexant"), and Specialtysemi, Inc., a Delaware corporation (the  "Company"). 

RECITALS  

        A.    As
contemplated by the Asset Contribution Agreement by and between Conexant, the Company, and Carlyle Capital Investors, L.L.C. dated February 23, 2002 (the  "Contribution Agreement"), the
Company has been formed to operate a semiconductor wafer fabrication facility currently located in Newport Beach,
California, and to carry out the business of providing semiconductor wafer fabrication and related services to Conexant and third parties. 

        B.    The
Parties desire that Conexant license certain intellectual property and technology to the Company for use by the Company in conducting this business, as set forth in
this Agreement. 

        NOW, THEREFORE, the Parties, intending to be legally bound, agree as follows: 

AGREEMENT  

1.    DEFINITIONS.    Capitalized terms not expressly
defined elsewhere in this Agreement have the following meanings: 

        1.1   "Affiliate" of a Party means any entity that at any time during the term
of this Agreement controls, is controlled by, or is under common control with such Party, where control means direct or indirect ownership of fifty percent (50%) or more of the outstanding voting
stock or other equity interests ordinarily having voting rights. 

        1.2   "Company Facilities" means all current and future semiconductor
fabrication facilities owned or operated by the Company or any current or future Affiliate of the Company. 

        1.3   "Conexant Spin-off" means any entity that is a successor of
any portion of the business of Conexant resulting from a spin-off, sale, or divestiture of such business, regardless of whether Conexant retains an equity or ownership interest in such
entity. Without limiting the foregoing, the Parties agree and acknowledge that Mindspeed Technologies and Conexant's wireless business (which is referred to within Conexant as "LeaderCo") are, or upon
the date of divestiture will be, Conexant Spin-offs. 

        1.4   "Customer" means a third party that engages the Company to fabricate
semiconductor wafers or devices for purchase by such third party. For purposes of this Agreement, notwithstanding the foregoing, [...***...] shall not be considered Customers. 

        1.5   "Design Kits" has the meaning given to such term in the Contribution
Agreement. 

        1.6   "Intellectual Property Rights" means any and all worldwide
(a) rights associated with works of authorship, including copyrights, moral rights, and mask works; (b) trade secret rights; (c) patents and patent rights; (d) other
proprietary rights in know-how, inventions, ideas, algorithms, formulae, methods, processes, techniques, proprietary information, software, semiconductor devices, and other types of
technology; and (e) all registrations, applications, renewals, extensions, combinations, divisions, or reissues of the foregoing. As used in this Agreement, however, the term "Intellectual
Property Rights" does not include trademark, trade name, or similar rights. 

        1.7   "Lemelson Agreement" means the Automotive Supplier Agreement between
Rockwell International Corporation and the Lemelson Medical, Education and Research Foundation dated December 31, 1998. 

        1.8   "Lemelson Licensed Field" means semiconductor products, services rendered
in connection therewith, and scientific research or development relating thereto. 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 

        1.9   "Lemelson Licensed Patents" means all patents licensed to Conexant in the
Lemelson Agreement. 

        1.10 "Licensed Materials" means any and all documents, information,
know-how, and materials related to the Process Technology, the ownership of which is not being (or has not been) assigned to the Company pursuant to the Contribution Agreement. 

        1.11 "Licensed Patents" means the patents listed on  Exhibit A, any and all patents issuing from the patent applications listed on Exhibit A,
and all continuations, continuations-in-part, counterparts (U.S. and foreign), divisionals, re-examinations, and reissues of such patents and patent applications. 

        1.12 "Party" means either Conexant or the Company, as the context requires,
and "Parties"means Conexant and the Company collectively. 

        1.13 "Process Technology" has the meaning given to such term in the
Contribution Agreement. 

        1.14 "Product Technology" has the meaning given to such term in the
Contribution Agreement. 

        1.15 "Rockwell Agreement" means the Distribution Agreement between Conexant
and Rockwell International Corporation dated December 31, 1998. 

        1.16 "Secondary Source" means a foundry engaged by a Customer to supply the
"overflow" quantity of semiconductor wafers or devices when the Company, due to capacity limitations, can only partially supply the Customer's needs for such semiconductor wafers or devices. In order
for a foundry to be considered a Customer's Secondary Source for a given semiconductor wafer or device, the Company must also be supplying the Customer with such semiconductor wafer or device. 

        1.17 "Wafer Fabrication Operations" has the meaning given to such term in the
Contribution Agreement. 

2.    PATENT LICENSE    

        2.1    License Grant.    Subject to the limitations expressly stated in this Agreement, Conexant hereby grants to the
Company a non-exclusive, worldwide, irrevocable, royalty-free and fully-paid license under the Licensed Patents to use the Process Technology (and perform the
associated methods and processes) at the Company Facilities in order to make, offer to sell, and sell semiconductor wafers and devices. This license will remain in effect until the expiration of the
last Licensed Patent to expire. 

        2.2    Assignments and Sublicensing.    Except as provided below and in Section 12.9, the Company may not
assign, sublicense, or otherwise transfer any of its rights under the license granted in Section 2.1 without the express, prior written consent of Conexant, which Conexant may grant or deny in
its discretion (it being understood that implied sublicenses arising under the "exhaustion" or "first sale" doctrine or similar legal principles are still allowed). The Company may grant sublicenses
under the license granted in Section 2.1 to Affiliates of the Company and in connection with the sale of all or any part of any business, business unit, division, or operation of the Company.
Before granting any such sublicense, the Company will ensure that the sublicensee has signed a binding written agreement containing, at a minimum, the terms set forth in  Exhibit B, and at
Conexant's request, the Company will provide a copy
of each such sublicense agreement. The Company may sublicense the rights granted in Section 2.1 to a third party for the purpose of enabling such third party to be a Secondary Source only with
Conexant's express, prior written consent, which Conexant may grant or deny in its discretion. 

3.    PROCESS TECHNOLOGY MATERIALS LICENSE    

        3.1    License Grant.    Subject to the limitations expressly stated in this Agreement, Conexant hereby grants to the
Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free and fully-paid license, under all of Conexant's applicable Intellectual Property Rights
(other than patent rights), to use the Licensed Materials (and, as necessary, to reproduce, modify, and create derivative 

2

 

works
of the documents, software, and other copyrighted materials included in the Licensed Materials) at the Company Facilities in order to use and improve the Process Technology to develop, improve,
make, offer to sell, and sell semiconductor wafers and devices. 

        3.2    Assignments and Sublicensing.    Except as provided below and in Section 12.9, the Company may not
assign, sublicense, or otherwise transfer any of its rights under the license granted in Section 3.1 without the express, prior written consent of Conexant, which Conexant may grant or deny in
its discretion (it being understood that implied sublicenses arising under the "exhaustion" or "first sale" doctrine or similar legal principles are still allowed). The Company may grant sublicenses
under the license granted in Section 3.1 to Affiliates of the Company and in connection with the sale of all or any part of any business, business unit, division, or operation of the Company.
Before granting any such sublicense, the Company will ensure that the sublicensee has signed a binding written agreement containing, at a minimum, the terms set forth in  Exhibit B, and at
Conexant's request, the Company will provide a copy of each such sublicense agreement. The Company may sublicense the rights
granted in Section 3.1 to a third party for the purpose of enabling such third party to be a Secondary Source only with Conexant's express, prior written consent, which Conexant may grant or
deny in its discretion. 

4.    DESIGN KITS LICENSE    

        4.1    License Grant.    Subject to the limitations expressly stated in this Agreement, Conexant hereby grants to the
Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free and fully-paid license, under all of Conexant's applicable Intellectual Property Rights
(other than patent rights), to (a) internally use, reproduce, modify, and create derivative works of the Design Kits for the sole purpose of providing design services to the Company's customers
(provided that in doing so, the Company does not use any proprietary or confidential documents, information, or materials furnished to the Company by Conexant or a Conexant Spin-off under
separate agreements concerning the manufacturing of products by the Company for Conexant or a Conexant Spin-off or the provision of fabrication, testing, assembly, packaging, or similar
services by the Company for Conexant or a Conexant
Spin-off); (b) distribute Design Kits to Customers and prospective Customers; and (c) grant to Customers and prospective Customers the right to use such Design Kits for the
sole purpose of designing semiconductor wafers and devices that are to be fabricated either by the Company (as the primary source), or by any Secondary Sources. Except as expressly set forth in the
foregoing sentence, Company will not distribute, sublicense, or otherwise grant to any third party any rights with respect to the Design Kits. 

        4.2    Assignments and Sublicensing.    Except as expressly provided in Section 4.1 or in Section 12.9,
the Company may not assign, sublicense, or otherwise transfer any of its rights under the license granted in Section 4.1 without the express, prior written consent of Conexant, which Conexant
may grant or deny in its discretion. The Company may grant sublicenses under the license granted in Section 4.1 to Affiliates of the Company and in connection with the sale of all or any part
of any business, business unit, division, or operation of the Company. Before granting any such sublicense, the Company will ensure that the sublicensee has signed a binding written agreement
containing, at a minimum, the terms set forth in Exhibit B, and at Conexant's request, the Company will provide a copy of each such sublicense
agreement. Any purported assignment or sublicense in violation of the foregoing will be null and void. 

        4.3    Third Party Software Licenses.    The Company understands and acknowledges that licenses to certain third-party
software included in the Design Kits are necessary in order to use the Design Kits, and that Conexant is not purporting to assign or sublicense any rights to such third-party software. The Company
agrees that it is responsible for obtaining all such third-party software licenses at its own expense and that it will obtain all such third-party software licenses. 

3

 

5.    ROCKWELL SUBLICENSE    

        5.1    Sublicense Grant.    Subject to the limitations expressly stated in this Agreement and any applicable
limitations in the Rockwell Agreement, Conexant hereby grants to the Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free and fully-paid
sublicense, under all Intellectual Property Rights licensed to Conexant under section 3.11(a) of the Rockwell Agreement that are related to the Wafer Fabrication Operations, to make, have made,
use, import, sell, or otherwise dispose of products or to practice any process in connection therewith. The sublicense granted in this Section 5.1 will remain in effect until the termination or
expiration of the license granted to Conexant in section 3.11(a) of the Rockwell Agreement. 

        5.2    Assignments and Sublicensing.    The Company may assign and sublicense its rights under the sublicense granted
in Section 5.1 to the maximum extent allowed under the terms of the Rockwell Agreement. 

6.    LEMELSON SUBLICENSE    

        6.1    Sublicense Grant.    Subject to all applicable limitations in the Lemelson Agreement, Conexant hereby grants to
the Company a non-exclusive, worldwide, irrevocable, royalty-free and fully-paid sublicense, under the Lemelson Licensed Patents: 

        (i)    to practice any and all inventions claimed therein either in support of or directly in the manufacture (including repair and
maintenance) of
products or providing services in the Lemelson Licensed Field and only in the Lemelson Licensed Field; 

         (ii)   to make, have made, use, sell, and lease any and all products, apparatus, methods, and services in and only in the Lemelson Licensed
Field; 

        (iii) to import into and export from any country of the world, all products and apparatus in and only in the Lemelson Licensed Field embodying the
inventions of the Lemelson Licensed Patents; and 

         (iv)  to use any and all methods and processes described and claimed therein for any and all licensed purpose, 

in
each case to the maximum extent allowed under the terms of the Lemelson Agreement. 

        6.2    Assignments and Sublicensing.    The Company may assign and sublicense its rights under the sublicense granted
in Section 6.1 to the maximum extent allowed under the terms of the Lemelson Agreement. 

7.    RESERVATION OF RIGHTS; LIMITATIONS    

        7.1    Ownership.    Conexant retains all rights (including ownership rights) in the Licensed Patents, Licensed
Materials, and Design Kits not expressly licensed to the Company in this Agreement. Nothing in this Agreement shall be construed, by implication or otherwise, to transfer to the Company title to, or
any
ownership interest in, the Licensed Patents, Licensed Materials, or Design Kits or any trademarks of Conexant, Conexant Affiliates, or Conexant Spin-offs. Without limiting the generality
of the foregoing, nothing in this Agreement shall be construed to grant the Company any license under any Conexant patent or patent application that is not listed on  Exhibit A and is not a
continuation, continuation-in-part, counterpart, divisional, re-examination, or
reissue of any patent or patent application listed on Exhibit A. 

        7.2    Product Technology Limitation.    Except as expressly provided in Section 4.1, and notwithstanding
anything else to the contrary in this Agreement, the licenses and sublicenses granted to the Company in this Agreement do not include, and nothing in this Agreement shall be construed as granting the
Company, any right to incorporate any of Conexant's Product Technology in any 

4

 

semiconductor
wafer, device, or other product or to use, reproduce, modify, or distribute any of Conexant's Product Technology in any other way. 

8.    CONFIDENTIALITY    

        8.1    Confidentiality Obligations.    The Parties acknowledge that any nonpublic information disclosed or provided by
one Party to another Party in connection with this Agreement will be subject to the Confidentiality Agreement between the Parties of even date herewith. Furthermore, the Parties agree that the Design
Kits and Licensed Materials are Confidential Information (as defined in such Confidentiality Agreement) of Conexant (it being understood that the designation of the Design Kits and Licensed Materials
as Confidential Information of Conexant will in no way limit the rights expressly licensed to the Company in this Agreement). 

        8.2    Terms of Agreement.    Neither Party will disclose any terms of this Agreement to anyone other than to
Affiliates, actual and prospective financing sources, actual and prospective investors, actual and prospective purchasers of all or substantially all of the assets of a Party or any business of such
Party, attorneys, accountants, and other professional advisors under a duty of confidentiality (or, in the case of Conexant, to Conexant Spin-offs), except as required by law or pursuant
to a mutually agreeable press release or to a third party under a duty of confidentiality in connection with a proposed sale of all or part of such Party's business. 

9.    [RESERVED]    

10.    DISCLAIMERS    

        10.1    General.    CONEXANT MAKES NO WARRANTIES IN THIS AGREEMENT WITH RESPECT TO ANY INTELLECTUAL PROPERTY RIGHTS
LICENSED OR SUBLICENSED TO THE COMPANY IN THIS AGREEMENT, AND DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES (OTHER THAN THE EXPRESS WARRANTIES IN THE CONTRIBUTION AGREEMENT), INCLUDING ANY
IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. 

        10.2    Specific.    Without limiting the generality of Section 10.1, nothing in this Agreement shall be
construed as giving rise to: 

	(a)
	a warranty or representation as to the validity or scope of any Intellectual Property Right licensed to the Company in the Agreement;
or

	(b)
	a warranty or representation that any manufacture, sale, or use of any products will not infringe the intellectual property rights of
others; or

	(c)
	an agreement to bring suit against third parties for infringement of any patent; or

	(d)
	an obligation to furnish any technical information or know-how to the Company. 

        10.3    Clarification.    Nothing in this Section 10 will impair any rights or remedies of either Party under
the Contribution Agreement. 

11.    LIMITATION OF LIABILITY    

        11.1    Consequential Damages.    EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THIS AGREEMENT, IN NO EVENT WILL EITHER
PARTY BE LIABLE TO THE OTHER PARTY FOR LOST PROFITS OR FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES ARISING FROM THE SUBJECT MATTER OF THIS AGREEMENT, REGARDLESS OF THE
TYPE OF CLAIM AND EVEN IF THAT PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 

5

 

        11.2    Liability Limit.    EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY'S AGGREGATE,
CUMULATIVE LIABILITY TO THE OTHER PARTY ARISING FROM OR RELATING TO THIS AGREEMENT, INCLUDING ANY APPLICABLE PENALTIES, [...***...]. THIS LIMITATION OF LIABILITY IS CUMULATIVE
WITH ALL PAYMENTS BEING AGGREGATED TO DETERMINE SATISFACTION OF THE LIMIT. THE EXISTENCE OF ONE OR MORE CLAIMS OR SUITS WILL NOT ENLARGE THE LIMIT. 

        11.3    Exceptions.    SECTIONS 11.1 AND 11.2 WILL NOT APPLY TO ANY BREACH OF SECTIONS 2.2, 3.2, 4.2, OR 7.2. NOTHING
IN THIS SECTION 11 SHALL BE CONSTRUED AS LIMITING EITHER PARTY'S RIGHTS OR REMEDIES UNDER THE CONTRIBUTION AGREEMENT. 

12.    GENERAL    

        12.1    Agency.    Under this Agreement (i) each Party will be deemed to be an independent contractor and not
an agent, joint venturer, or representative of the other Party; (ii) neither Party may create any obligations or responsibilities on behalf of or in the name of the other Party; and
(iii) neither Party will hold itself out to be a partner, employee, franchisee, representative, servant, or agent of the other Party. 

        12.2    Governing Law; Venue and Jurisdiction.    This Agreement will be governed by, subject to, and construed in
accordance with the internal laws of the State of Delaware, as such laws apply to contracts between Delaware residents performed entirely within Delaware. The Parties agree that the United Nations
Convention on Contracts for the International Sale of Goods will not apply to this Agreement. 

        12.3    Dispute Resolution.    The Parties will act in good faith and use commercially reasonable efforts to promptly
resolve any claim, dispute, controversy or disagreement arising out of or relating to or in connection with this Agreement or the breach, termination or validity hereof (each a  "Dispute") between the Parties under or related to this Agreement or any of the transactions
contemplated hereby. 

        (a)   Upon the written request (a "Request") of a Party, the other Party shall
commence good faith negotiations with the goal of resolving the Dispute on a mutually satisfactory basis. If the Dispute has not been resolved to the satisfaction of the Parties within
[...***...] after the date on which the Request is delivered, the Dispute shall immediately be referred to senior officers of each Party. The senior officers of each Party
(e.g., chief executive officer and/or chief executive officer of international business) shall meet immediately, and in no case later than
[...***...] after the date on which the Request is delivered, for a minimum of [...***...] with a mutually selected mediator and attempt in good faith
to negotiate a resolution of the Dispute. If the Parties are unable to resolve the Dispute within [...***...] after the date on which the Request is delivered, then any
relevant Party may submit the Dispute to arbitration as the exclusive means of resolving it in accordance with the procedures set forth in this Section 12.3. 

        (b)   Except as otherwise specified in this Section 12.3, any Dispute not resolved through the procedure set forth above
shall be finally settled by arbitration in accordance with the International Rules and Procedures of the American Arbitration Association (the "Arbitration
Rules"), which are deemed to be incorporated by reference herein except as otherwise modified herein. 

        (c)   The arbitration situs shall be Wilmington, Delaware, and the laws of the State of Delaware shall be applied. 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

6

 

        (d)   In the event of arbitration, there shall be one arbitrator who shall be jointly nominated by the Parties. If the Parties
fail to so nominate the arbitrator within [...***...] from the date on which the Dispute is submitted to arbitration pursuant to this Section 12.3, at the request of any
Party, the arbitrator shall be appointed in accordance with the Arbitration Rules. 

        (e)   The arbitration hearing shall commence no later than [...***...] following the appointment of the
sole arbitrator, and the final award shall be rendered no later than [...***...] following the close of the hearing. 

        (f)    Consistent with the expedited nature of arbitration, each Party will, upon the written request of the other Party,
provide the other with copies of documents relevant to the issue raised by any claim or counterclaim. Other discovery may be ordered by the arbitrator to the extent the arbitrator deems additional
discovery relevant and appropriate, and any dispute regarding discovery, relevance or scope thereof, shall be determined by the arbitrator, which determination shall be conclusive. 

        (g)   By agreeing to arbitration, the Parties do not intend to deprive any court of its jurisdiction to issue a
pre-arbitral injunction, pre-arbitral attachment, injunctive or other equitable relief or an order in aid of arbitration proceedings and the enforcement of any award. Without
prejudice to such provisional remedies in aid of arbitration as may be available under the jurisdiction of a national court, the arbitral tribunal shall have full authority to grant provisional
remedies and to award damages for the failure of any party to respect the arbitral tribunal's orders to that effect. 

        (h)   The award shall be final and binding upon the Parties, and shall be the sole and exclusive remedy between the Parties
regarding any claims, counterclaims, issues, or accounting presented to the arbitral tribunal in connection with the Dispute. Judgment upon any award may be entered in any court having competent
jurisdiction thereof. 

        (i)    The costs of the arbitration shall be borne as determined in accordance with the Arbitration Rules;  provided,
 however, that to the extent a Party is non-prevailing or unsuccessful on a claim in an arbitration proceeding under this
Section 12.3 as determined by the arbitrator, that Party shall pay the prevailing or successful Party's costs and expenses incurred in connection with the arbitration of that Dispute, including
attorneys' fees and arbitration expenses, whether or not such Dispute is prosecuted to award or judgment. 

        (j)    Subject to the receipt of any applicable governmental approval, any monetary award shall be made and promptly payable in
U.S. dollars, if due in U.S. dollars, free of any deduction or offset, and the arbitral tribunal shall be authorized in its discretion to grant pre-award and post-award
interest at commercial rates. The arbitral tribunal shall have the authority to award any remedy or relief proposed by the claimants or respondents pursuant to this Agreement, including without
limitation, a declaratory judgment, specific performance of any obligation created under this Agreement or the issuance of an injunction. 

        (k)   Notwithstanding anything to the contrary in this Section 12.3, either Party may seek injunctive relief in any
court of competent jurisdiction as it deems necessary to protect its Intellectual Property Rights. 

        12.4    Sublicenses.    The Company agrees that will not exceed the scope of the sublicenses granted to it in this
Agreement. 

        12.5    Export Laws.    The Company agrees that it will not, in the course of exercising the rights licensed or
sublicensed to it in this Agreement, export or reexport, resell, ship, or divert or cause to be exported or reexported, resold, shipped, or diverted directly or indirectly any software, documentation,
or technical data incorporating any software to any country for which the government (or any agency thereof) of the United States, or any foreign sovereign government with competent jurisdiction
requires an export license or other governmental approval without first obtaining such license or approval. 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

7

 

        12.6    Bankruptcy.    The Parties acknowledge and agree that this Agreement is a contract under which the Company is
a licensee of a right to intellectual property as provided in Section 365(n) of Title 11, United States Code. 

        12.7    Amendment; Later Agreement.    This Agreement may not be amended, modified, or supplemented by the Parties in
any manner, except by an instrument in writing signed by Conexant and Company and specifically reciting that it amends this Agreement. No purchase order or acknowledgement will amend this Agreement.
All matters designated herein as subject to agreement of the Parties must be agreed upon in a writing signed by authorized representatives of both Parties for such agreement to be effective. 

        12.8    Notices.    Any notice, consent, approval, or other communication intended to have legal effect to be given
under this Agreement must be in writing and will be delivered (as elected by the Party giving such notice): (i) personally; (ii) by postage prepaid registered or certified airmail,
return receipt requested; (iii) by express courier service; or (iv) by facsimile with a confirmation copy deposited prepaid with an express courier service. Unless otherwise provided
herein, all notices will be deemed to have been duly given on: (y) the date of receipt (or if delivery is refused, the date of such refusal) if delivered personally, by mail, or by express
courier; or (z) one (1) business day after receipt by telecopy if the telecopy was accompanied by the mailing of the notice via mail or courier service. Each Party may change its address
for purposes hereof on not less than three (3) days' prior notice to the other Party. Notice hereunder will be sent to the following addresses (with a copy to the legal department): 

	If to Conexant, to:	 	If to the Company, to:
	

Conexant Systems, Inc.

4311 Jamboree Road

Newport Beach, CA 92660

Attn: General Counsel

Facsimile: (949) 483-9576	
 	

Carlyle Capital Investors, L.L.C.

c/o The Carlyle Group

101 S. Tryon Street, 25th Floor

Charlotte, N.C., 28280

Attn: Claudius E. Watts, IV

Facsimile: (704) 632-0299
	

with a copy to:	
 	

with a copy to:
	

Cooley Godward LLP

4401 Eastgate Mall

San Diego, CA 92121

Attn: Carl R. Sanchez, Esq.

Facsimile: (858) 550-6420	
 	

Latham & Watkins

555 11th Street N.W., Ste 1000

Washington, D.C., 20004-1304

Attn: Raymond B. Grochowski, Esq.

Facsimile: (202) 637-2201

        12.9    Assignment.    Except as otherwise expressly provided in this Agreement, neither Party shall assign or
transfer this Agreement or all or any part of its rights or obligations hereunder, by operation of law or otherwise, without the prior written consent of the other Party. Notwithstanding the
foregoing, either Party may assign this Agreement, in whole or in part, without the consent of the other Party: to (i) any Affiliate; (ii) a successor in the event of a merger or
acquisition of all or substantially all of the assets of such Party; or (iii) a successor of any portion of the business of a Party resulting from a divestiture of such business; provided that
such assignee shall agree in writing to be bound by the terms and conditions contained herein. In addition to the foregoing, each Party may assign all of its rights to any person providing financing
to such Party as collateral security for such financing, provided that no such assignment shall relieve such Party from any of its obligations hereunder and such assignee shall agree in writing to be
bound by the terms and conditions contained herein. In no event, however, may either Party assign any intellectual property licenses or rights granted in this Agreement to a bankruptcy trustee or in
connection with bankruptcy or insolvency proceedings, and each Party agrees that it will not assign any rights under this Agreement to its Affiliates, or grant sublicenses to its 

8

 

Affiliates,
as part of a sham transaction intended to circumvent the general prohibition on assigning rights or granting sublicenses to third parties. Any unauthorized assignment or transfer shall be
null and void. This Agreement shall be binding upon and inure solely to the benefit of each Party and its successors and permitted assigns. 

        12.10    Waiver.    If a Party fails to insist on performance of any of the terms and conditions of this Agreement, or
fails to exercise any of its rights or privileges under this Agreement, such failure will not constitute a waiver of such terms, conditions, rights, or privileges. 

        12.11    Severability.    If the application of any provision or provisions of this Agreement to any particular facts
or circumstances is held to be invalid or unenforceable by any court of competent jurisdiction, then: (i) the validity and enforceability of such provision or provisions as applied to any other
particular facts or circumstances and the validity of other provisions of this Agreement will not in any way be affected or impaired thereby; and (ii) such provision or provisions will be
reformed without further action by the Parties and only to the extent necessary to make such provision or provisions valid and enforceable when applied to such particular facts and circumstances. 

        12.12    Counterparts and Facsimile.    This Agreement may be executed in any number of counterparts, each of which
when so executed and delivered will be deemed an original, and such counterparts together will constitute one and the same instrument. The Parties intend that each Party will receive a duplicate
original of the counterpart copy or copies executed by it. For purposes hereof, a facsimile copy of this Agreement, including the signature pages hereto, will be deemed to be an original. 

        12.13    Rules of Construction.    As used in this Agreement, all terms used in the singular will be deemed to include
the plural, and vice versa, as the context may require. The words "hereof," "herein," and "hereunder" refer to this Agreement as a whole, including the attached exhibits, as the same may from time to
time be amended or supplemented, and not to any subdivision in this Agreement. When used in this Agreement, unless otherwise expressly stated, "including" means "including, without limitation"
and "discretion" means sole discretion. Unless otherwise expressly stated, when a Party's approval or consent is required under this Agreement, such Party may grant or withhold its approval or consent
in its discretion. References to "Section" or "Exhibit" will be to the applicable section or exhibit of this Agreement. Descriptive headings are inserted for convenience only and will not be utilized
in interpreting this Agreement. This Agreement has been negotiated by the Parties and reviewed by their respective counsel and will be fairly interpreted in accordance with its terms and without any
strict construction in favor of or against either Party. 

        12.14    Entire Agreement.    As to the subject matter hereof: (i) this Agreement, including its exhibits, sets
forth the entire agreement between Conexant and Company; (ii) no promise, inducement, understanding, or agreement not expressly contained herein has been made; and (iii) this Agreement
merges and supersedes any and all previous agreements, understandings, and negotiations between the Parties. The foregoing shall not be construed to amend or in any way modify the Contribution
Agreement or the rights and remedies of the parties thereto. 

        IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date by the undersigned duly authorized representatives
of each Party. 

	CONEXANT SYSTEMS, INC.	 	SPECIALTYSEMI, INC.
	

By:	
 	

/s/  DWIGHT DECKER      	
 	

By:	
 	

/s/  CLAUDIUS E. WATTS IV      
	 	 	
	 	 	 	

	Name:	 	Dwight Decker	 	Name:	 	Claudius E. Watts IV
	 	 	
	 	 	 	

	Title:	 	Chief Executive Officer	 	Title:	 	President
	 	 	
	 	 	 	

9

 
EXHIBIT A

LICENSED PATENTS

[...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

10

 
EXHIBIT B  

 MINIMUM TERMS  

A.    When
the sublicensee is a Company Affiliate or a purchaser of all or any part of any Company business, business unit, division, or operation: 

	1.
	The
sublicensee may use the Process Technology, Design Kits, and Licensed Materials subject to the sublicense only at Company Facilities (in the case of sublicenses to Company
Affiliates) or facilities owned or operated by the purchaser or its Affiliates (in the case of sublicenses to a purchaser of all or any part of any Company business unit, division, or operation).

	2.
	The
sublicensee may grant further sublicenses with respect to the Process Technology, Design Kits, and Licensed Materials only to its Affiliates and in connection with the sale of all
or any part of any of its business units, divisions, or operations. Before granting any such sublicense, the sublicensee must ensure that the sub-sublicensee has signed a binding written
agreement containing, at a minimum, the terms set forth in part A of this Exhibit B. At the request of the Company or Conexant, the
sublicensee will provide a copy of each such sublicense agreement.

	3.
	The
sublicensee may not disclose, provide, or otherwise make the Licensed Materials or Design Kits (or any portion thereof that has not become generally available to the public through
no fault of the sublicensee, that was not provided to the sublicensee by a third party free of any confidentiality duties or obligations, or that the sublicensee can prove was independently developed
by employees or contractors of the sublicensee without reference to the Licensed Materials or Design Kits) available to any third party (except that the sublicensee may distribute the Design Kits to
Customers and prospective Customers to the same extent, and subject to the same conditions and limitations, as the Company can distribute the Design Kits to Customers under Section 4).

	4.
	The
sublicensee must limit access to the Licensed Materials and Design Kits to those of its employees who have a need to know, who have confidentiality obligations no less restrictive
than those set forth herein, and who have been informed of the confidential nature of Licensed Materials and Design Kits.

	5.
	The
sublicensee must protect the Licensed Materials and Design Kits from unauthorized use, access, or disclosure in the same manner as it protects its own Confidential Information of a
similar nature, and in no event with less than reasonable care.

	6.
	When
the sublicensee no longer has a valid license to use the Licensed Materials or Design Kits (or any portion thereof), the sublicensee must return to the Company or destroy (or in
the case of electronic files permanently erase) all software, information, data, documents, and materials included in the Licensed Materials or Design Kits (or such portion thereof), except that the
sublicensee may retain one archival copy solely for evidentiary purposes.

	7.
	The
sublicensee must comply with the limitations on the use, distribution, and sublicensing of the Design Kits set forth in Section 4 of this Agreement. 

B.    When
the sublicensee is a Customer or Prospective Customer (only for sublicenses to the Design Kits): 

	1.
	The
Customer's or Prospective Customer's use of the Design Kits is limited designing semiconductor wafers and devices that are to be fabricated either by the Company (as the primary
source), or by any Secondary Sources.

	2.
	The
Customer or Prospective Customer is not allowed to distribute or sublicense use of the Design Kits to any third party. 

11

 
	3.
	The
Customer or Prospective Customer is allowed to reproduce the software, information, data, documents, and materials included in the Design Kits only to the extent reasonably
necessary to use the Design Kits in accordance with paragraph #1 and to manufacture (or have manufactured), market, distribute, and sell the products designed by the Customer or Prospective Customer
with the Design Kits.

	4.
	The
Customer or Prospective Customer may not disclose, provide, or otherwise make the Design Kits (or any portion thereof that has not become generally available to the public through
no fault of the Customer or Prospective Customer, that was not provided to the Customer or Prospective Customer by a third party free of any confidentiality duties or obligations, or that the Customer
or Prospective Customer can prove was independently developed by employees or contractors of the Customer or Prospective Customer without reference to the Design Kits) available to any third party.

	5.
	The
Customer or Prospective Customer must limit access to the Design Kits to those of its employees who have a need to know, who have confidentiality obligations no less restrictive
than those set forth herein, and who have been informed of the confidential nature of Design Kits.

	6.
	The
Customer or Prospective Customer must protect the Design Kits from unauthorized use, access, or disclosure in the same manner as it protects its own Confidential Information of a
similar nature, and in no event with less than reasonable care.

	7.
	When
the Customer or Prospective Customer no longer has a valid license to use the Design Kits (or any portion thereof), the Customer or Prospective Customer must return to the Company
or destroy (or in the case of electronic files permanently erase) all software, information, data, documents, and materials included in the Design Kits (or such portion thereof), except that the
Customer or Prospective Customer may retain one archival copy solely for evidentiary purposes. 

12

QuickLinks

Exhibit 10.6

IP LICENSE AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}]]